NDN and head and neck carcinoma: In other studies (e.g., Aarts et al, 2019), both NDN from healthy subjects and those from patients with head-and-neck carcinoma or mammary carcinoma inhibit T-cell proliferation only if they have been activated by the presence of formyl peptide fMLF.